<DOC>
	<DOCNO>NCT02517944</DOCNO>
	<brief_summary>Patients familial hypercholesterolemia ( FH ) high cardiovascular risk may suffer silent micro-infarctions ( MI ) clinical coronary heart disease manifestation lifetime exposure elevate serum LDL-cholesterol level . The study aim demonstrate high prevalence silent myocardial infarction population asymptomatic patient familial hypercholesterolemia high cardiovascular risk comparison control patient use Cardiac Magnetic Resonance sequence delay gadolinium enhancement .</brief_summary>
	<brief_title>MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA ( CHOLCOEUR )</brief_title>
	<detailed_description>To demonstrate high prevalence silent myocardial infarction population asymptomatic patient familial hypercholesterolemia high cardiovascular risk comparison control patient , protocol following : - enroll 75 patient familial hypercholesterolemia ( FH ) - enroll 35 subject without FH ( control group ) - subject , collect data medical file ( blood test result ) perform cardiac aortic MRI order evaluate micro-infarction proportion . The study perform accord GCPs respect french law .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<criteria>Inclusion criterion : For patient heterozygous form familial hypercholesterolemia : Aged 40 60 year With identified genetic mutation ( LDLR , ApoB , PCSK9 ) Asymptomatic , With EKG sign ischemia No personal history coronary heart disease . Treated untreated lipid lower treatment High cardiovascular risk identify 1 follow criterion : 1 . Current smoking ( 1 cigarette day ) 2 Family history premature onset CHD : first seconddegree male relative onset age 45 , first seconddegree female relative onset age 55 3.Two cardiovascular risk factor among list : increasing age ( men &gt; 30 , woman &gt; 40 year age ) , LDLC &gt; 250 mg/dL , male sex , family history premature onset CHD , firstdegree male relative onset age 55 , firstdegree female relative onset age 65 , metabolic syndrome , HDLC &lt; 40 mg/dL , hypertension ( BP &gt; 140/or &gt; 90 mmHg drug treatment ) , Lp ( ) â‰¥ 50 mg/dL , tendon xanthoma For control subject : Aged 40 60 year With normal lipid profile ( LDLC &lt; 1.6g/L HDLC &gt; 0,45g/L TG &lt; 4g/L ) untreated lipid lower therapy Asymptomatic , With EKG show normal sinus rhythm , sign ischemia Left Bundle Branch Block No personal history coronary heart disease . Control subject match age/gender/smoking status blood pressure Exclusion criterion : Nonaffiliation healthcare system Consent refusal Contraindication MRI gadolinium injection . Claustrophobia , metallic device , pacemaker , mechanical valve implanted 1985 , pregnancy , nurse Renal failure Technical contraindication : patient diameter &gt; 70 cm weight &gt; 250 kg Personal history cardiovascular disease myocardial infarction Diabetes mellitus Uncontrolled hypertension TG &lt; 4 g/L Previous use Amgen product past 12 month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Familial hypercholesterolemia</keyword>
</DOC>